Social

Dive into sound with Suunto Aqua

SYDNEY,March 3,2025-- Suunto brings high-quality underwater audio with the Suunto Aqua. This advanced bone-conduction headset elevates audio technology to new heights,offering a seamless experience fo

VVDN Launches AI-Powered Wi-Fi 7 Access Point Reference Designs Powered by the Qualcomm Dragonwing NPro A7 Platform at MWC Barcelona

GURUGRAM,India,March 3,2025--VVDN Technologies,a global provider of Software,Product Engineering and Electronics Manufacturing services and Solution,has announced a collaboration with Qualcomm Techno

Recommend

Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological Laboratories

Mar 18, 2025

DeepRoute.ai Expands Beyond Smart Driving Cars with AI Spark Platform to Achieve RoadAGI

Mar 18, 2025

Celebrating Sixty Years Of Innovation, Influence, And Impact: Alliance Manchester Business School (AMBS) Looks Back On A Business Education Legacy Spanning Decades

METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

Pegatron 5G with Industrial Partners Optimizes Private Networks at MWC 2025

All News

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

G-P Expands Availability of G-P Gia™; Welcomes Leaders to the Next Era of HR

The smartest AI global HR advisor,G-P Gia,thinks like a lawyer and cuts the cost and time of compliance by up to 95%; reducing the need to outsource legal in 50 countries and 50 U.S. states

Lessons from Japan's AMR Response for the Global Community

https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned

Innovation and technology fuels winter economy in Harbin

BEIJING,Feb. 25,2025-- A news report from China Daily: Harbin,capital of Heilongjiang province in Northeast China,has become a popular destination for ice and snow tourism in recent years.